首页> 外国专利> METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID

METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID

机译:通过修饰含或不含维甲酸的19-或不含维生素D的类似物来治疗和全面治疗痤疮和其他皮肤状况的方法

摘要

Oral and topical pharmaceutical compositions, kits and methods of treatment thereof for treating various skin disorder including acne, psoriasis, ichthyosis, photoaging, photodamaged skin, and, skin cancer. Exemplary vitamin D analogs as active pharmaceutical ingredients include 2-methylene-19-nor-20(S)-1α-hydroxy-bishomopregnacalciferol, 19-nor-26,27-dimethylene-20(S)-2-methylene-1α,25-dihydroxyvitamin D3, 2-methylene-1α,25-dihydroxy-(17E)-17(20)-dehydro-19-nor-vitamin D3, 2-methylene-19-nor-(24R)-1α,25-dihydroxyvitamin D2, 2-methylene-(20R,25S)-19,26-dinor-1α,25-dihydroxyvitamin D3, 2-methylene-19-nor-1α-hydroxy-pregnacalciferol, 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol, (20R)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, 2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol, 2-methylene-23,23-difluoro-1α-hydroxy-19-nor-bishomopregnacalciferol, 2-methylene-(20S)-23,23-difluoro-1α-hydroxy-19-nor-bishomopregnancalciferol, (2-(3′hydroxypropyl-1′,2′-idene)-19,23,24-trinor-(20S)-1α-hydroxyvitamin D3, 2-methylene-18,19-dinor-(20S)-1α,25-dihydroxyvitamin D3, a stereoisomer thereof, a prodrug thereof in oral compositions, a salt thereof, and/or a solute thereof. Compounds that activate retinoic acid receptors, such as retinoyls and retinoyl esters, include 13-cis-retinoic acid, all-trans-retinoic acid, (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexeneyl)nona-2,4,6,8-tetraenoic acid, 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid, 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-napthoic acid, 4-[1-(3,5,5,8,8-pentamethyl-tetralin-2-yl)ethenyl]benzoic acid, retinobenzoic acid, ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate, retinoyl t-butyrate, retinoyl pinacol, retinoyl cholesterol, an isomer thereof, a prodrug thereof for oral compositions, an ester thereof, a salt thereof, and/or, a solute thereof. Combinations of such active ingredients demonstrate synergistic efficacy.
机译:用于治疗包括痤疮,牛皮癣,鱼鳞病,光老化,光老化,光损伤的皮肤和皮肤癌在内的各种皮肤疾病的口服和局部用药物组合物,试剂盒及其治疗方法。作为活性药物成分的示例性维生素D类似物包括2-亚甲基-19-nor-20(S)-1α-羟基-双商品孕降钙素醇,19-nor-26,27-二亚甲基-20(S)-2-亚甲基-1α,25 -二羟基维生素D 3 ,2-亚甲基-1α,25-二羟基-(17E)-17(20)-脱氢-19-正维生素D 3 ,2-亚甲基-19-nor-(24R)-1α,25-二羟基维生素D 2 ,2-亚甲基-(20R,25S)-19,26-dinor-1α,25-二羟基维生素D 3 ,2-亚甲基-19-nor-1α-羟基-孕烯钙化醇,1α-羟基-2-亚甲基-19-nor-全朴素钙化醇,(20R)-1α-羟基-2-亚甲基-19-nor-nor- Bisomopregnacalciferol,2-methyl-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol,2-methyl-23,23-difluoro-1α-hydroxy-19-nor-bishomopregnacalciferol,2-methyl-(20S)-23, 23-difluoro-1α-hydroxy-19-nor-bishomopregnancalciferol,(2-(3'hydroxypropyl-1',2'-idene)-19,23,24-trinor-(20S)-1α-hydroxyvitaminD 3 ,2-亚甲基-18,19-二价-(20S)-1α,25-二羟基维生素D 3 ,其立体异构体,其前药口服组合物,其盐和/或其溶质。激活视黄酸受体的化合物,例如视黄酸和视黄酸酯,包括13-顺-视黄酸,全反式视黄酸,(2E,4E,6Z,8E)-3,7-二甲基-9-(2, 6,6-三甲基-1-环己烯基)nona-2,4,6,8-丁烯酸,9-(4-甲氧基-2,3,6-三甲基-苯基)-3,7-二甲基-nona-2 ,4,6,8-四烯酸,6- [3-(1-金刚烷基)-4-甲氧基苯基] -2-萘甲酸,4- [1-(3,5,5,8,8-五甲基-四氢化萘-2-基)乙烯基]苯甲酸,视黄基苯甲酸,6- [2-(2-(4,4-二甲基硫代吡喃-6-基)乙炔基]吡啶-3-羧酸乙酯],视黄基叔丁酸酯,视黄基频哪醇,视黄基胆固醇,异构体,其口服组合物的前药,其酯,其盐和/或其溶质。这些活性成分的组合显示出协同功效。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号